Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Fisher, N. Slack, D. Katrych, N. Wolmark (1975)
Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.Surgery, gynecology & obstetrics, 140 4
B. Ponder (1992)
Molecular Genetics of CancerNature Medicine, 2
H. Hausen (1977)
Human papillomaviruses and their possible role in squamous cell carcinomas.Current topics in microbiology and immunology, 78
H.-J. Lindemann (1971)
Eine neue Untersuchungsmethode für die HysteroskopieEndoscopy, 03
F. Li, J. Fraumeni (1969)
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?Annals of internal medicine, 71 4
J. Marks, A. Davidoff, B. Kerns, P. Humphrey, J. Pence, R. Dodge, D. Clarke‐Pearson, J. Iglehart, R. Bast, A. Berchuck, C-P, Medicine, Microbiology Immunology (1991)
Overexpression and mutation of p53 in epithelial ovarian cancer.Cancer research, 51 11
(1991)
Assessment of current international federation of gynecology and obstetrics staging of vulvar carcinoma relative to prognostic factors for survival ( a GOG study )
(1969)
Ein neues vaginales Schnittbildverfah
(1976)
Phase II study of cisdichlo - rodiamine platinum ( II ) in advanced adenocarcinoma of the ovary
R. Knapp, E. Friedman (1974)
Aortic lymph node metastases in early ovarian cancer.American journal of obstetrics and gynecology, 119 8
J. Bishop (1987)
The molecular genetics of cancer.Science, 235 4786
(1991)
Over - expression and mutation of p 53 in epithelial ovarian cancer
Jensen Ev, G. Block, S. Smith, K. Kyser, Desombre Er (1971)
Estrogen receptors and breast cancer response to adrenalectomy.National Cancer Institute monograph, 34
(1978)
Ergebnisse bei Reihenuntersuchungen mit Mammographie und Thermographie in Hamburg
(1965)
Die Therapie des Ovarialkarzinoms mit Zytostatika
M. Turco, D. Palli, A. Cariddi, S. Ciatto, P. Pacini, V. Distante (1994)
Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized TrialJAMA, 271
E. Burghardt, H. Pickel, J. Haas, M. Lahousen (1987)
Prognostic factors and operative treatment of stages IB to IIB cervical cancer.American journal of obstetrics and gynecology, 156 4
(1992)
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.Lancet, 339 8784
C. Morrow, B. Bundy, R. Kurman, W. Creasman, P. Heller, H. Homesley, J. Graham (1991)
Relationship between surgical‐pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group studyInternational Journal of Gynecology & Obstetrics, 36
A. Bois, H. Lück, T. Bauknecht (1999)
First-Line Chemotherapy in Advanced Ovarian Cancer: State of the Art and Future AspectsOncology Research and Treatment, 22
S. Jones (1981)
Adjuvant chemotherapy for breast cancer.JAMA, 245 15
Richard Cooper, J. Holland, O. Glidewell (1979)
Adjuvant chemotherapy of breast cancerCancer, 44
D. Slamon, W. Godolphin, L. Jones, J. Holt, Steven Wong, D. Keith, W. Levin, S. Stuart, J. Udove, A. Ullrich, M. Press (1989)
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.Science, 244 4905
N. Auersperg, S. Maines-Bandiera, P. Kruk (1995)
Human ovarian surface epithelium: growth patterns and differentiation
C. Griffiths (1975)
Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.National Cancer Institute monograph, 42
In den letzten Jahrzehnten vollzog sich auch auf dem Gebiet der gynäkologischen Onkologie ein grundlegender Wandel – dafür stehen Meilensteine. In der Natur der klinischen Medizin liegt jedoch, daß die für die Entwicklung, Diagnostik und Therapie relevanten «Meilensteine» erst dann, wenn sie sich bewährt und als dauerhaft erwiesen haben, als solche zu erkennen sind. Deshalb darf es nicht verwundern, daß sie auf dem Gebiet der gynäkologischen Onkologie meist schon vor über 20 Jahren gesetzt wurden. Obwohl es heute scheint, als seien zur Diagnose und Therapie gynäkologischer Karzinome keine grundlegend neuen Gesichtspunkte und Techniken hinzugekommen, gab es in dieser Zeit gravierende Veränderungen. ...
Oncology Research and Treatment – Karger
Published: Dec 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.